Artemis Medicare Services Ltd

Artemis Medicare Services Ltd experienced a notable decline today, touching an intraday low of Rs 220.55, reflecting a sharp price pressure of -7.87% amid a broader market environment that saw mixed momentum. The stock underperformed its sector and the benchmark Sensex, continuing a three-day losing streak with heightened volatility.

Artemis Medicare Services Ltd., the Gurugram-based multi-specialty hospital operator, reported a robust 40.84% quarter-on-quarter surge in consolidated net profit to ₹29.97 crores for Q3 FY26, marking a significant improvement from ₹21.28 crores in the previous quarter. On a year-on-year basis, profitability jumped 34.64% from ₹22.26 crores in Q3 FY25. However, the stock faced considerable selling pressure, declining 3.11% to ₹239.60 following the results announcement, reflecting investor concerns over valuation and long-term growth sustainability despite the impressive quarterly performance.

Artemis Medicare Services Ltd has seen its investment rating downgraded from Buy to Hold as of 1 February 2026, reflecting a shift in technical indicators and a nuanced financial performance. While the company continues to demonstrate strong operational growth and healthy debt metrics, recent technical trends and valuation concerns have tempered enthusiasm among analysts.

Artemis Medicare Services Ltd has experienced a notable shift in price momentum, transitioning from a mildly bullish trend to a sideways pattern, as reflected in its latest technical indicators. Despite a marginal day-to-day price change, the stock’s technical landscape reveals a complex interplay of bearish and bullish signals across weekly and monthly timeframes, prompting a reassessment of its near-term outlook.

Artemis Medicare Services Ltd is rated 'Buy' by MarketsMOJO. This rating was last updated on 08 Dec 2025, reflecting a positive outlook on the stock. However, all fundamentals, returns, and financial metrics discussed below are current as of 25 January 2026, providing investors with the latest comprehensive view of the company’s position.

Artemis Medicare Services Ltd is rated Buy by MarketsMOJO, with this rating last updated on 08 December 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 14 January 2026, providing investors with the most recent insights into its performance and outlook.

Artemis Medicare Services Ltd is rated Buy by MarketsMOJO, with this rating last updated on 08 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 03 January 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Artemis Medicare Services Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late December 2025. Despite a recent decline in share price, the stock's technical indicators present a complex picture, with some metrics signalling strength while others suggest caution. This article analyses the latest technical parameters, price momentum, and market context to provide a comprehensive view for investors.

Artemis Medicare has experienced a revision in its market evaluation, reflecting shifts in its financial and technical outlook. This change highlights evolving perspectives on the company’s operational strength, valuation appeal, and market momentum within the hospital sector.

Artemis Medicare Services, a key player in the hospital sector, has exhibited a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent market data reveals a nuanced picture of price action and technical indicators, suggesting evolving investor sentiment and potential implications for future price trends.

Artemis Medicare Services, a key player in the hospital sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a strongly bullish stance to a more mildly bullish outlook, underscoring the evolving market dynamics for this healthcare stock.

Artemis Medicare Services, a key player in the hospital sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a mildly bearish stance to a more bullish technical outlook, underscoring evolving market dynamics for the stock.

Artemis Medicare Services has recently formed a Golden Cross, a significant technical indicator where the 50-day moving average crosses above the 200-day moving average. This development often signals a potential shift towards a bullish trend, suggesting renewed investor confidence and a possible long-term momentum change for the hospital sector stock.

Artemis Medicare Services has experienced a revision in its market assessment following a detailed review of its quality, valuation, financial trends, and technical indicators. While the company continues to demonstrate robust financial performance in several areas, recent technical signals and market returns have prompted a nuanced reassessment of its investment profile.

Artemis Medicare Services, a key player in the hospital sector, is currently exhibiting a nuanced shift in its technical momentum as recent evaluation adjustments reflect a blend of bullish and bearish signals across multiple timeframes. The stock’s price action and technical indicators suggest a complex market assessment, warranting close attention from investors and analysts alike.